SCHEMBL6133301

SCHEMBL6133301

CCOC(=O)c1nc(-c2ccccc2)c(-c2ccc(=O)[nH]n2)s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
HSD17B10 Q99714 2/20 0.49
HPGDS O60760 1/20 0.48
HPGD P15428 1/20 0.47
PTGS2 P35354 1/20 0.47
CYP1A2 P05177 3/20 0.46
DHODH Q02127 3/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CDC7 O00311 2/20 0.46
DBF4 Q9UBU7 2/20 0.46
RARA P10276 1/20 0.44
RARB P10826 1/20 0.44
RARG P13631 1/20 0.44
GSTO1 P78417 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
GALR3 O60755 1/20 0.43
KDM4E B2RXH2 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6134289 0.82 KDM4E (0.44) ALDH1A1HPGDCYP1A2MEN1KMT2A
SCHEMBL6133155 0.82 CYP1A2 (0.50) ALDH1A1HPGDPTGS2CYP1A2CYP2C19
SCHEMBL6133796 0.81 ADORA2A (0.50) ALDH1A1CYP1A2CYP2C9CYP2C19MEN1
SCHEMBL6828786 0.81 HPGDS (0.49) ALDH1A1HSD17B10HPGDSHPGDPTGS2
SCHEMBL6134322 0.80 PTGS2 (0.46) ALDH1A1HSD17B10HPGDPTGS2CYP1A2
SCHEMBL6133966 0.79 HTT (0.52) ALDH1A1HSD17B10HPGDPTGS2CYP1A2
SCHEMBL6828733 0.78 HPGDS (0.47) ALDH1A1HSD17B10HPGDSHPGDPTGS2
SCHEMBL6133924 0.77 PTGS2 (0.44) ALDH1A1HSD17B10HPGDPTGS2CYP1A2
SCHEMBL6133474 0.77 HTT (0.50) ALDH1A1HSD17B10HPGDPTGS2CYP1A2
SCHEMBL6133344 0.76 SMN1; SMN2 (0.55) HSD17B10PTGS2CYP1A2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2005-01-06 US disclosed
EP-1441732-A2 THIAZOLE DERIVATIVE AND PHARMACEUTICAL USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-04 EP disclosed
WO-2003039451-A2 THIAZOLE PYRIDAZINONES AS ADENOSINE ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-05-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof MC2R, CYP2C9, OXTR ALDH1A1 630/4885HSD17B10 391/4885HPGDS 1899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.